SEARCH

SEARCH BY CITATION

References

  • 1
    Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 37489.
  • 2
    Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 135.
  • 3
    Kramer MS. Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol 1981; 11(Suppl 1): 105S110S.
  • 4
    Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 758.
  • 5
    Karch FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasagna L. Adverse drug reactions – a matter of opinion. Clin Pharmacol Ther 1976; 19: 48992.
  • 6
    Feinstein AR. Clinical biostatistics. XXX. Biostatistical problems in ‘compliance bias’. Clin Pharmacol Ther 1974; 16: 84657.
  • 7
    Blanc S, Leuenberger P, Berger JP, Brooke EM, Schelling JL. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 4938.
  • 8
    Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther 1995; 58: 6928.
  • 9
    Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol 1989; 42: 516.
  • 10
    Begaud B. Dictionary of pharmacoepidemiology. Chichester: Wiley, 2000.
  • 11
    Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000; 320: 1036.
  • 12
    Pere JC, Begaud B, Haramburu F, Albin H. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther 1986; 40: 45161.
  • 13
    Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 23945.
  • 14
    Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Safety 2005; 14: 88590.
  • 15
    Hutchinson TA, Flegel KM, HoPingKong H, Bloom WS, Kramer MS, Trummer EG. Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 1983; 34: 4216.
  • 16
    Miremont G, Haramburu F, Begaud B, Pere JC, Dangoumau J. Adverse drug reactions: physicians' opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 2859.
  • 17
    Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, Haramburu F. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005; 61: 16973.
  • 18
    Venulet J, Ciucci A, Berneker GC. Standardized assessment of drug–adverse reaction associations – rationale and experience. Int J Clin Pharmacol Ther Toxicol 1980; 18: 3818.
  • 19
    Meyboom RH. Causality assessment revisited. Pharmacoepidemiol Drug Safety 1998; 7(Suppl 1): S635.
  • 20
    Leventhal JM, Hutchinson TA, Kramer MS, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians. JAMA 1979; 242: 19914.
  • 21
    Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions. Comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 2003; 28: 13743.